MAP3K13 Antikörper (Ser869)
Kurzübersicht für MAP3K13 Antikörper (Ser869) (ABIN2587009)
Target
Alle MAP3K13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Ser869
-
Spezifität
- This MAP3K13 (LZK) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 854-884 amino acids from the C-terminal region of human MAP3K13 (LZK).
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: ELISA (1:1000), IHC (1:10 - 1:50), WB (1:100 - 1:500)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Andere Bezeichnung
- MAP3K13 / LZK
-
Hintergrund
-
Name/Gene ID: MAP3K13
Subfamily: MLK(MAP3K)
Family: Protein Kinase
Synonyms: MAP3K13, Leucine zipper-bearing kinase, LZK, Mixed lineage kinase, MLK, MEKK13 -
Gen-ID
- 9175
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Target
-